Dexcom (DXCM) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 244.00 |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 963.00 |
| Mar 31, 2026 | 1,505.00 |
| Dec 31, 2025 | 1,026.00 |
| Sep 30, 2025 | 89.00 |
| Jun 30, 2025 | 731.00 |
| Mar 31, 2025 | 634.00 |
| Dec 31, 2024 | 1,688.00 |
| Sep 30, 2024 | -291.00 |
| Jun 30, 2024 | -124.00 |
| Mar 31, 2024 | 189.00 |
| Dec 31, 2023 | 269.00 |
| Sep 30, 2023 | 229.00 |
| Jun 30, 2023 | -30.00 |
| Mar 31, 2023 | -193.00 |
| Dec 31, 2022 | -655.00 |
| Sep 30, 2022 | 504.00 |
| Jun 30, 2022 | 1,130.00 |
| Mar 31, 2022 | 1,170.00 |
| Dec 31, 2021 | 4,878.00 |
| Sep 30, 2021 | 1,298.00 |